The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA

Nature. 1989 Mar 16;338(6212):254-7. doi: 10.1038/338254a0.

Abstract

Human immunodeficiency virus type 1 (HIV-1) replication requires the expression of two classes of viral mRNA. The early class of HIV-1 transcripts is fully spliced and encodes viral regulatory gene products. The functional expression of one of these nuclear regulatory proteins, termed Rev (formerly Art or Trs), induces the cytoplasmic expression of the incompletely spliced, late class of HIV-1 mRNAs that encode the viral structural proteins, including Gag and Env. Here, we provide evidence that this induction reflects the export from the cell nucleus to the cytoplasm of a pool of unspliced viral RNA constitutively expressed in the nucleus. The hypothesis that Rev acts on RNA transport, rather than splicing, is further supported by the observation that the cytoplasmic expression of a non-spliceable HIV-1 env gene sequence is also subject to Rev regulation. Here we show that this Rev response requires a specific target sequence which coincides with a complex RNA secondary structure present in the env gene. The response to Rev is fully maintained when this sequence is relocated to other exonic or intronic locations within env but is ablated by inversion. These results indicate that the HIV-1 rev gene product induces HIV-1 structural gene expression by activating the sequence-specific nuclear export of incompletely spliced HIV-1 RNA species.

MeSH terms

  • Base Sequence
  • Cell Nucleus / metabolism
  • Chromosome Mapping
  • Cytoplasm / metabolism
  • Gene Products, rev
  • Genes, Regulator*
  • HIV-1 / genetics*
  • Molecular Sequence Data
  • RNA, Messenger / metabolism
  • RNA, Viral / metabolism
  • Transfection
  • Viral Proteins / physiology*
  • rev Gene Products, Human Immunodeficiency Virus

Substances

  • Gene Products, rev
  • RNA, Messenger
  • RNA, Viral
  • Viral Proteins
  • rev Gene Products, Human Immunodeficiency Virus